Bleeding rates per 100 patient-years in valid-for-safety analysis set
| . | All patients . | SPAF . | VTE . | P value: SPAF vs VTE . |
|---|---|---|---|---|
| n (%) | 1775 (100) | 1200 (67.6) | 575 (32.4) | |
| Any bleeding, % (95% CI) | 59.4 (55.2-63.9) | 59.3 (54.4-64.6) | 59.6 (51.7-68.4) | .4989 |
| Minor bleeding, % (95% CI) | 36.3 (33.2-39.7) | 35.8 (32.2-39.7) | 37.8 (31.8-44.6) | .4199 |
| NMCR bleeding, % (95% CI) | 19.7 (17.6-22.1) | 20.7 (18.1-23.5) | 17.2 (13.5-21.6) | .1585 |
| Major bleeding, % (95% CI) | 3.4 (2.6-4.4) | 3.1 (2.2-4.3) | 4.1 (2.5-6.4) | .2849 |
| . | All patients . | SPAF . | VTE . | P value: SPAF vs VTE . |
|---|---|---|---|---|
| n (%) | 1775 (100) | 1200 (67.6) | 575 (32.4) | |
| Any bleeding, % (95% CI) | 59.4 (55.2-63.9) | 59.3 (54.4-64.6) | 59.6 (51.7-68.4) | .4989 |
| Minor bleeding, % (95% CI) | 36.3 (33.2-39.7) | 35.8 (32.2-39.7) | 37.8 (31.8-44.6) | .4199 |
| NMCR bleeding, % (95% CI) | 19.7 (17.6-22.1) | 20.7 (18.1-23.5) | 17.2 (13.5-21.6) | .1585 |
| Major bleeding, % (95% CI) | 3.4 (2.6-4.4) | 3.1 (2.2-4.3) | 4.1 (2.5-6.4) | .2849 |